BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 31228075)

  • 21. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
    Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
    World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-infrared dye-labeled antibody COC183B2 enables detection of tiny metastatic ovarian cancer and optimizes fluorescence-guided surgery.
    Chen J; Guo Y; Li H; Zhang C; Chang X; Ma R; Cheng H; Ye X; Cui H; Li Y
    J Surg Oncol; 2020 Nov; 122(6):1207-1217. PubMed ID: 32705686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.
    Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP
    Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
    Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
    Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIR-II nano fluorescence image guided hepatic carcinoma resection on cirrhotic patient.
    Zhang Z; Fang C; Zhang Y; Su S; Li B; Liu G; Hu Z; Tian J
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103098. PubMed ID: 36055624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.
    Meng Q; Liu Z; Li F; Ma J; Wang H; Huan Y; Li Z
    Mol Pharm; 2015 Jul; 12(7):2469-76. PubMed ID: 26030093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
    Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal.
    Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Yamamoto Y; Morimura R; Ikoma H; Okamoto K; Kamiya M; Urano Y; Otsuji E
    Sci Rep; 2021 Sep; 11(1):17946. PubMed ID: 34504174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
    Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
    J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery.
    Tashiro Y; Aoki T; Hirai T; Koizumi T; Kusano T; Matsuda K; Yamada K; Nogaki K; Hakozaki T; Wada Y; Shibata H; Tomioka K; Yamazaki T; Saito K; Fujimori A; Enami Y; Hoffman RM
    Anticancer Res; 2022 Mar; 42(3):1345-1350. PubMed ID: 35220226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
    Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J
    Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
    Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
    J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near infrared-emitting persistent luminescent nanoparticles for Hepatocellular Carcinoma imaging and luminescence-guided surgery.
    Ai T; Shang W; Yan H; Zeng C; Wang K; Gao Y; Guan T; Fang C; Tian J
    Biomaterials; 2018 Jun; 167():216-225. PubMed ID: 29573651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.
    Yamamura K; Beppu T; Sato N; Kinoshita K; Oda E; Yuki H; Motohara T; Miyamoto H; Komohara Y; Akahoshi S
    Anticancer Res; 2020 Oct; 40(10):5823-5828. PubMed ID: 32988911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
    Negmeldin AT; Pflum MKH
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Decitabine (5-aza-2'-deoxycytidine, 5-aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines.
    Sanaei M; Kavoosi F; Pourahmadi M
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2089-2098. PubMed ID: 34319031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.